Here's How the Novavax COVID Shot Held Up Against Omicron

(MedPage Today) -- During the 2022 Omicron wave, Novavax's protein-based COVID shot had an estimated 50% vaccine effectiveness (VE) against symptomatic infection in fully vaccinated people and a VE of 31% in those who were partially vaccinated...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news